Cantor Fitzgerald Downgrades CVS Health to Neutral, Lowers Price Target to $58
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James downgraded CVS Health (NYSE:CVS) from Overweight to Neutral and reduced the price target from $87 to $58, indicating a more cautious outlook on the company's stock.
May 01, 2024 | 5:54 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Cantor Fitzgerald downgraded CVS Health to Neutral from Overweight and lowered the price target to $58 from $87.
The downgrade from Overweight to Neutral by a prominent analyst, along with a significant reduction in the price target, suggests a bearish outlook on CVS Health's stock in the short term. This could lead to decreased investor confidence and a potential drop in stock price as market participants adjust their expectations based on this new analysis.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100